..
Highlight: Claims Sinovac-other vaccine combo has lower efficacy ‘misrepresentation of prevailing facts and evidence’, says ICR – https://t.co/UUengEO2rS https://t.co/BvNC2lGDfk
— The Edge Malaysia (@theedgemalaysia) February 10, 2022
..
This Pharmaniaga statement — which MOH's ICR denounced as having "misrepresented" facts and evidence — failed to mention that the Yale study did NOT compare Sinovac vs Pfizer boosters and that two Sinovac doses showed no "detectable" neutralizing antibodies against Omicron. pic.twitter.com/NUrQemN9Ji
— Boo Su-Lyn (@boosulyn) February 10, 2022
Hence why one of the authors of the Yale-Dominican Republic study suggested that Sinovac recipients may need two boosters to protect against Omicron, instead of one.
— Boo Su-Lyn (@boosulyn) February 10, 2022
Because 1 Pfizer booster + 2 Sinovac doses only raises protection to 2 mRNA doses.https://t.co/uHXepJJGeJ
Now let's talk about comparing Pfizer and Sinovac boosters, since Pharmaniaga's statement implicitly compared both through two wholly unrelated & separate studies.
— Boo Su-Lyn (@boosulyn) February 10, 2022
Pharmaniaga carefully avoids saying outright that a Sinovac booster offers more protection than a Pfizer booster. pic.twitter.com/XfVzmNXRwj
Hong Kong study shows a Pfizer booster for double-vax Sinovac recipients improved protection against Omicron, but 3 Sinovac doses did not produce sufficient neutralizing antibodies.
— Boo Su-Lyn (@boosulyn) February 10, 2022
Hence researchers recommend Pfizer booster for Sinovac recipients.https://t.co/9928YlM3nZ pic.twitter.com/5vUU9LG4Tp
Brazil study shows a booster of either AstraZeneca, Johnson & Johnson, or Pfizer for double-vaccinated Sinovac recipients produced much stronger immune responses against both Delta and Omicron than a third Sinovac dose.https://t.co/Hsn210Zkxy pic.twitter.com/7Ptx6b8cWq
— Boo Su-Lyn (@boosulyn) February 10, 2022
..
weehingthong 